S. 1302 · 119th Congress · Health

Increasing Transparency in Generic Drug Applications Act

In committee675 words Introduced Apr 3, 2025 · Latest action Apr 3, 2025

How far it has goneStage 2 of 6
  1. IntroducedApr 3, 2025 Done
  2. CommitteeReferred to Health, Education, Labor, and Pensions Current stage
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

10 organizations · 44 filings · Q2 2025–Q3 2026

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Viatris (mylan, Inc) 6 of 6 quarters
    “Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H.R. 1843; Part D Formulary Design and Generic Drug Testing”

    Q3 2026 filing · $1.3M lobbying spend in 2026 to date, all issues

  2. Association for Accessible Medicines 5 of 6 quarters
    “Prescription Drug Costs. H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. S.1302: Increasing Transparency in Generic Drug Applications Act. Drug Shortages. H.R.4191/S.1784: Mapping Americas Pharmaceutical Supply (MAPS) Act. H.R.4132/S.2027: Prescription…”

    Q3 2026 filing · $2.5M lobbying spend in 2026 to date, all issues

  3. Blue Cross Blue Shield of Michigan 5 of 6 quarters
    “Issues: Generics access; Prescription Drug Cost; PBM Reform and Prescription Drug Policy Bills: S.3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1096 - Preserve Access to Affordable…”

    Q3 2026 filing · $829K lobbying spend in 2026 to date, all issues

7 more organizations, every filingPROUpgrade

Organizations that named S. 1302 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Apr 3, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Apr 3, 2025Introduced in Senate

What members said about it